ARCHIVES

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

NIH Awards 24 More Grants For Women’s Health Initiative

October 14, 1994

ACS Awards Grants Totaling $31.3 Million

January 25, 1985

Cancer Cases To Double By 2050, Annual Report Says

May 31, 2002

Regular Exercise May Prevent Cancer, Improve Survival

April 30, 2004

DCCP Board Okays New Projects In Chemoprevention, Other Programs Totaling $5 Million In First Year

December 14, 1979

NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors

December 4, 1998